Why the study?
Does old age alter the pharmacokinetics of single-dose digoxin compared to young patients?
Does old age alter the pharmacokinetics of single-dose digoxin compared to young patients?
Elderly patients exhibit reduced plasma clearance and a longer half-life of digoxin, highlighting the pharmacokinetic basis for age-related dose adjustments.
Answers are grounded in this paper and cite their sources.
May support age-adjusted digoxin dosing; leaves open prospective outcome validation in elderly.
A study of single-dose digoxin kinetics was performed in 6 young and 7 elderly patients. The rate of absorption, determined by the time to peak concentration after an oral dose, was more rapid in the younger group. The extent of absorption, as measured by comparison of the area under the plasma concentration/time curve after oral and intravenous administration, was similar in both groups. Mean plasma half-life was longer and individual values were more variable in the elderly patients. The absolute apparent volume of distribution was reduced in the older patients and correlated inversely with age. When corrected for weight, however, the difference in the apparent volume of distribution did not approach significance. Both absolute and weight-corrected values for plasma clearance of digoxin were reduced in the elderly subjects.
No takes yet. Share an insight, caveat, or question.
Cusack et al. (1979) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: